Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 1c 1125,"Rubattu S, et al., Nat Genet 1996 Aug;13(4):429-34",cerebrovascular system integrity trait,,RS:0001444,SHRSP/Bbb,both,84 days,30,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69117,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days) 1125,"Rubattu S, et al., Nat Genet 1996 Aug;13(4):429-34",cerebrovascular system integrity trait,,RS:0003421,SHR/Bbb,both,182 days,30,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,20,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 140 days) and controlled sodium content drinking water (1 %) (for 140 days) and controlled potassium content diet (6.3 mg/g) (for 140 days),69118,controlled sodium content diet (3.7 mg/g) (for 140 days),controlled sodium content drinking water (1 %) (for 140 days),controlled potassium content diet (6.3 mg/g) (for 140 days)